Work

Abstract CT241: A phase 1, first-in-human (FIH) study of autologous anti-HER2 chimeric antigen receptor macrophage (CAR-M) in participants (pt) with HER2 overexpressing solid tumors

Year: 2023

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2023-ct241

Authors: Yara Abdou, E. Claire Dees, Joanne Mortimer, Naoto Ueno, Melissa Johnson, Richard Maziarz, Jennifer Specht, Yuan Yuan, Paula Puhlman, Mathew Angelos, Saar Gill, Amy Ronczka, Thomas Condamine, Daniel J. Cushing, Michael Klichinsky, Debora Barton, Ramona F. Swaby, Kim Reiss Binder

Institutions: UNC Lineberger Comprehensive Cancer Center, City Of Hope National Medical Center, The University of Texas MD Anderson Cancer Center, Sarah Cannon, Oregon Health & Science University, OHSU Knight Cancer Institute, Fred Hutch Cancer Center, Abramson Cancer Center, University of Pennsylvania, Carisma Therapeutics (United States)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4365512283

Cites:

Cited by: 2

Related to: 10